Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 11/20 | 1.00 |
| ▸ | PTPN2 | P17706 | 7/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 0.73 |
| ▸ | F3 | P13726 | 3/20 | 0.73 |
| ▸ | AKR1B10 | O60218 | 3/20 | 0.73 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.73 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.73 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.73 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.73 |
| ▸ | PTPRC | P08575 | 2/20 | 0.73 |
| ▸ | PTPRF | P10586 | 2/20 | 0.73 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.73 |
| ▸ | CES1 | P23141 | 2/20 | 0.73 |
| ▸ | ACP1 | P24666 | 2/20 | 0.73 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.73 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.73 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.73 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.73 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.73 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14642424 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL25981456 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL178210 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL4462388 | 0.87 | PTPN1 (0.76) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL974587 | 0.85 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL31593848 | 0.85 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL974588 | 0.85 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| SCHEMBL6913431 | 0.85 | PTPN1 (0.73) | PTPN1PTPN2POLBF3AKR1B10 | |
| Oleanolic_Acid SCHEMBL24916648 | 0.84 | PTPN1 (1.00) | PTPN1PTPN2POLBF3AKR1B10 | |
| Oleanolic_Acid SCHEMBL22009261 | 0.84 | PTPN1 (1.00) | PTPN1PTPN2POLBF3AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023238945-A1 | FINE HAIR-INDUCING AGENT | ＭＥＤ Ｒ＆Ｄ株式会社 | 2023-12-14 | — | — | WO | claimed |
| WO-2023238945-A1 | FINE HAIR-INDUCING AGENT | ＭＥＤ Ｒ＆Ｄ株式会社 | 2023-12-14 | — | — | WO | disclosed |
| CN-108003214-B | Saponin compound extracted from rhizoma bolbostemmae, and its preparation method and application | 成都普思生物科技股份有限公司 | 2020-05-19 | — | — | CN | disclosed |
| CN-108003214-A | A kind of saponin compound and its methods and applications extracted from the rhizoma bolbostemmae | 成都普思生物科技股份有限公司 | 2018-05-08 | — | — | CN | disclosed |
| EP-1910844-B1 | CROSS-BETA STRUCTURE BINDING COMPOUNDS | CROSSBETA BIOSCIENCES BV (NL) | 2012-04-18 | — | — | EP | disclosed |
| EP-2386861-A2 | Cross-ß structure binding compounds | Crossbeta Biosciences B.V. (NL) | 2011-11-16 | — | — | EP | disclosed |
| US-8041447-B2 | Numerical controller having workpiece setting error compensation means | FANUC LTD (JP) | 2011-10-18 | — | — | US | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |
| US-7465466-B2 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | INTEGRATED CHINESE MEDICINE HOLDINGS, LTD. (HK) | 2008-12-16 | — | — | US | disclosed |
| US-7449202-B1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | INTEGRATED CHINESE MEDICINE HOLDINGS, LTD. (HK) | 2008-11-11 | — | — | US | disclosed |
| US-7223424-B2 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | INTEGRATED CHINESE MEDICINE HOLDINGS, LTD. (HK) | 2007-05-29 | — | — | US | disclosed |
| US-20060210657-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | SIBONI GROUP LIMITED (HK) | 2006-09-21 | — | — | US | disclosed |
| US-20050136140-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | SIBONI GROUP LIMITED (HK) | 2005-06-23 | — | — | US | disclosed |
| US-6855344-B2 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | INTEGRATED CHINESE MEDICINE HOLDINGS, LTD. (HK) | 2005-02-15 | — | — | US | disclosed |
| US-20030134000-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | SIBONI GROUP LIMITED (HK) | 2003-07-17 | — | — | US | disclosed |
| US-20030108629-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | INTEGRATED CHINESE MEDICINE HOLDINGS, LTD. (CN) | 2003-06-12 | — | — | US | disclosed |
| WO-2003037246-A2 | COMPOSITIONS AND METHODS FOR PROSTATE AND KIDNEY HEALTH AND DISORDERS, AN HERBAL PREPARATION | INTEGRATED CHINESE MEDICINE HOLDINGS LTD. (CN) | 2003-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108629-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | ALPI, ERGIC1, BPHL | PTPN1 4319/4885PTPN2 4147/4885POLB 4234/4885 |
| US-20060210657-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | ALPI, ERGIC1, BPHL | PTPN1 4319/4885PTPN2 4147/4885POLB 4234/4885 |
| US-20050136140-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | ALPI, NR1I3, CCNI | PTPN1 4188/4885PTPN2 4103/4885POLB 4229/4885 |
| US-20030134000-A1 | Compositions and methods for prostate and kidney health and disorders, an herbal preparation | ALPI, ERGIC1, BPHL | PTPN1 4319/4885PTPN2 4147/4885POLB 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.